document4

Upload: arief-budiarto

Post on 12-Oct-2015

6 views

Category:

Documents


0 download

DESCRIPTION

ding

TRANSCRIPT

e despite continued exposure to the vasodilating stimulus [14, 26, 32]. Teleologically, this active opposition to prolonged pulmonary vasodilation in the fetal lung prevents a steal of blood flow from the placenta, the fetal organ of gas exchange. However, endothelium-independent agents that directly increase smooth muscle cell cGMP levels were found to cause sustained pulmonary vasodilation during prolonged infusions [33, 34]. Mechanisms contributing to this time-dependent autoregulatory response are unknown, but may include decreased production of endogenous nitric oxide by the endothelial and smooth muscle cells, down-regulation of guanylate cyclase, or increased release of vasoconstricting mediators such as endothelin-1.Conclusion and PerspectivesIn conclusion, we found that sildenafil induces a potent but transient pulmonary vasodilation in the fetus. Although the effects of sildenafil on the basal pulmonary vascular tone are transient, sildenafil causes prolonged changes in pulmonary vasoreactivity. Especially, sildenafil increases the pulmonary hemodynamic responses to increased fetal PaO2 and to acute DA compression. These results support the hypothesis that PDE5 is involved in the control of the basal pulmonary vascular tone and in the regulation of the pulmonary vascular reactivity to birth-related events during the perinatal life.Pulmonary hypertension is associated with elevated pulmonary vascular tone and abnormal pulmonary vasoreactivity. Especially, the pulmonary vascular response to increased O2 tension and to change in hemodynamic forces are markedly impaired in persistent pulmonary hypertension of the newborn [7, 9]. Chronic pulmonary hypertension impairs flow-induced vasodilation and augments a myogenic response, causing a paradoxical vasoconstriction to increase in pulmonary pressure [9]. As sildenafil increases the pulmonary vascular response to birth-related stimuli, we speculate that PDE5 inhibitor treatment may have a therapeutic impact on perinatal pulmonary hypertension.Back to Article OutlineThis work was supported by Grants from Dlgation la Recherche du CHRU de Lille, Facult de Mdecine de Lille, Universit de Lille II, Fondation de France, Fondation de lAvenir, and by Journes Francophones de Recherche en Nonatologie.Back to Article OutlineReferences

  1. TeitelDF, IwmotoH, RudolphAM. Effects of birth related events on central blood flow patterns. Pediatr Res. 1987;22:557566
    • View In Article
    • MEDLINE
    • CrossRef
  2. LevinDL, HeymanMA, KittermanJA, GregoryGA, PhibbsRH, RudolphAM. Persistent pulmonary hypertension of the newborn. J Pediatr. 1976;89:626630
    • View In Article
    • Abstract
    • Full-Text PDF (403 KB)
    • CrossRef
    WaltherFJ, BendersMJ, LeightonJO. Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome. Pediatrics. 1992;90:899904
  • View In Article
  • MEDLINE

LewisAB, HeymannMA, RudolphAM. Gestational changes in pulmonary vascular responses in fetal lambs in utero. Circ Res. 1976;39:536541

  • View In Article
  • MEDLINE
  • CrossRef

TsaiBM, WangM, TurrentineMW, Mahomed Y, BrownJW, MeldrumDR. Hypoxic pulmonary vasoconstriction in cardiothoracic surgery (basic mechanisms to potential therapies). Ann Thorac Surg. 2004;78:360368

  • View In Article
  • Abstract
  • Full Text
  • Full-Text PDF (174 KB)
  • CrossRef

IvyDD, KinsellaJP, AbmanSH. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J Clin Invest. 1994;93:21412148

  • View In Article
  • MEDLINE
  • CrossRef

CornfieldDN, ChatfieldBA, McQuestonJA, McMurtryIF, AbmanSH. Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus. Am J Physiol. 1992;262:H1474H1481

  • View In Article
  • MEDLINE

ZengeJP, RairighRL, GroverTR, etal.NO and prostaglandin interactions during hemodynamic stress in the fetal ovine pulmonary circulation. Am J Physiol Lung Cell Mol Physiol. 2001;281:L1157L1163View In ArticleMEDLINEStormeL, RairighRL, ParkerTA, KinsellaJP, AbmanSH. In vivo evidence for a myogenic response in the fetal pulmonary circulation. Pediatr Res. 1999;45:425431

  • View In Article
  • MEDLINE
  • CrossRef

KabbaniMS, CassinS. The effects of cGMP on fetal sheep pulmonary blood flow and lung liquid production. Pediatr Res. 1998;43:325330

  • View In Article
  • MEDLINE
  • CrossRef

Rabe KF, TenorH, DentG, SchudtC, NakashimaM, MagnussenH. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Am J Physiol. 1994;266:L536L543

  • View In Article
  • MEDLINE

HansonKA, Burns F, RybalkinSD, MillerJW, BeavoJ, ClarkeWR. Developmental changes in lung cGMP phosphodiesterase-5 activity, protein, and message. Am J Respir Crit Care Med. 1998;158:279288

  • View In Article
  • CrossRef

DukarmRC, RussellJA, MorinFC, PerryBJ, SteinhornRH. The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation. Am J Respir Crit Care Med. 1999;160:858865View In ArticleCrossRefZieglerJW, IvyDD, FoxJJ, KinsellaJP, ClarckeWR, AbmanSH. Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus. Am J Respir Crit Care Med. 1998;157:11041110

  • View In Article
  • CrossRef

AndersonDF, BissonetteJM, FarberJJ, ThornburgKL. Central shunt flows and pressures in the mature fetal lamb. Am J Physiol. 1981;241:H60H66

  • View In Article
  • MEDLINE

Michelakis ED, TymchakW, NogaM, etal.Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation. 2003;108:20662069

  • View In Article
  • CrossRef

SchermulyRT, KreisselmeierKP, GhofraniHA, etal.Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats. Am J Respir Crit Care Med. 2004;169:3945

  • View In Article
  • CrossRef

ZhaoL, MasonNA, MorrellNW, et al.Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation. 2001;104:424428

  • View In Article
  • CrossRef
GhofraniHA, WiedemannR, RoseF, etal.Sildenafil for treatment of lung fibrosis and pulmonary hypertension (a randomised controlled trial). Lancet. 2002;360:895900
  • View In Article
  • Abstract
  • Full Text
  • Full-Text PDF (88 KB)
  • CrossRef

GhofraniHA, VoswinckelR, ReichenbergerF, et al.Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (a randomized prospective study). J Am Coll Cardiol. 2004;44:14881496

  • View In Article
  • Abstract
  • Full Text
  • Full-Text PDF (319 KB)
  • CrossRef

GilliesHC, RoblinD, Jackson G. Coronary and systemic hemodynamic effects of sildenafil citrate (from basic science to clinical studies in patients with cardiovascular disease). Int J Cardiol. 2002;86:131141

  • View In Article
  • Abstract
  • Full Text
  • Full-Text PDF (93 KB)
  • CrossRef

RichaletJP, GratadourP, RobachP, etal.Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am J Respir Crit Care Med. 2005;171:275281

  • View In Article
  • CrossRef

SanchezLS, de la MonteSM, FilippovG, JonesRC, ZapolWM, BlochKD. Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development. Pediatr Res. 1998;43:163168

  • View In Article
  • MEDLINE
  • CrossRef

MorenoL, Losada B, CogolludoA, etal.Postnatal maturation of phosphodiesterase 5 (PDE5) in piglet pulmonary arteries (activity, expression, effects of PDE5 inhibitors, and role of the nitric oxide/cyclic GMP pathway). Pediatr Res. 2004;56:563570

  • View In Article
  • MEDLINE
  • CrossRef
ZieglerJW, IvyDD, FoxJJ, KinsellaJP, ClarkeWR, AbmanSH. Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus. Am J Physiol. 1995;269:H473H479
  • View In Article
  • MEDLINE

AbmanSH, AccursoFJ. Acute effects of partial compression of ductus arteriosus on fetal pulmonary circulation. Am J Physiol. 1989;257:H626H634

  • View In Article
  • MEDLINE

McMahonTJ, IgnarroLJ, KadowitzPJ. Influence of zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed. J Appl Physiol. 1993;74:17041711

  • View In Article

ThusuKG, Morin FC, RussellJA, SteinhornRH. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Am J Respir Crit Care Med. 1995;152:16051610

  • View In Article
  • CrossRef

ZieglerJW, IvyDD, WigginsJW, KinsellaJP, ClarkeWR, AbmanSH. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension. Am J Respir Crit Care Med. 1998;158:13881395

  • View In Article
  • CrossRef

WangP. Characterization of human, dog and rabbit corpus cavernosum type 5 phosphodiesterases. Life Sci. 2001;68:19771987

  • View In Article
  • MEDLINE
  • CrossRef

RybalkinSD, YanC, BornfeldtKE, BeavoJA. Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res. 2003;93:280291

  • View In Article
  • CrossRef

JaillardS, Houfflin-DebargeV, RiouY, etal.Effects of catecholamines on the pulmonary circulation in the ovine fetus. Am J Physiol Regul Integr Comp Physiol. 2001;281:R607R614

  • View In Article
  • MEDLINE

AbmanSH, AccursoFJ. Sustained fetal pulmonary vasodilation with prolonged atrial natriuretic factor and GMP infusions. Am J Physiol. 1991;260:H183H192

  • View In Article
  • MEDLINE

DeruelleP, GroverTR, StormeL, AbmanSH. Effects of BAY 41-2272, a soluble guanylate cyclase activator, on pulmonary vascular reactivity in the ovine fetus. Am J Physiol. 2005;288:L727L733

  • View In Article

PII:S0003-4975(05)01623-1doi:10.1016/j.athoracsur.2005.09.022 2006 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved. PreviousNext The Annals of Thoracic Surgery
Volume 81, Issue 3 , Pages 935-942, March 2006Print or Share This Pagehttp://s7.addthis.com/js/250/addthis_widget.js#pub=xa-4b1d65bd00983246Access this article on ScienceDirect Visit ScienceDirect to see if you have access via your institution. Article Tools

  • Download Images*
  • Email Abstract
  • Add to My Reading List
  • Rights/Permissions
  • Request Reprints
  • Related Articles
  • (7) Cited in Scopus
  • Export Citation
  • Create Citation Alert

*Image Usage & Resolution

Copyright 2013 Elsevier Inc. All rights reserved.|Privacy Policy|Terms & Conditions|Feedback|About Us|Help| Contact Us
The content on this site is intended for health professionals.Advertisements on this site do not constitute a guarantee or endorsement by the journal, Association, or publisher of the quality or value of such product or of the claims made for it by its manufacturer. var _gaq = _gaq || []; _gaq.push(['_setAccount', 'UA-20599307-9']); _gaq.push(['_trackPageview']); (function() { var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); })();

lK ua'W>6QUm5g+-JZBNI}|k-bYw;T,|@c",Z(FZ+g#&l?'V%y#!rr NO-independent, haem-dependent soluble g... [Handb Exp Pharmacol. 2009] - PubMed - NCBI

var ncbi_startTime = new Date();

var ObjectLinks=[{i:0, ename: "p$ExL", esid:"*", sname: "p$ExL", ssid:"*", dname:"p$el", dsid:"0",m:"CopyValue",p:[],f: function(src, dst) {fn_CopyValue(src, dst);}}]var ActiveNames = {"p$ExL":1, "EntrezSystem2.PEntrez.DbConnector.Cmd":0, "EntrezSystem2.PEntrez.DbConnector.Db":0, "EntrezSystem2.PEntrez.DbConnector.IdsFromResult":0, "EntrezSystem2.PEntrez.DbConnector.LastDb":0, "EntrezSystem2.PEntrez.DbConnector.LastIdsFromResult":0, "EntrezSystem2.PEntrez.DbConnector.LastQueryKey":0, "EntrezSystem2.PEntrez.DbConnector.LastTabCmd":0, "EntrezSystem2.PEntrez.DbConnector.LinkName":0, "EntrezSystem2.PEntrez.DbConnector.LinkReadableName":0, "EntrezSystem2.PEntrez.DbConnector.LinkSrcDb":0, "EntrezSystem2.PEntrez.DbConnector.QueryKey":0, "EntrezSystem2.PEntrez.DbConnector.TabCmd":0, "EntrezSystem2.PEntrez.DbConnector.Term":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_PageController.PreviousPageName":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.EmailTab.Email":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.EmailTab.EmailCount":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.EmailTab.EmailFormat":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.EmailTab.EmailQueryKey":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.EmailTab.EmailReport":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.EmailTab.EmailSort":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.EmailTab.EmailStart":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.EmailTab.EmailSubject":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.EmailTab.EmailText":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.EmailTab.QueryDescription":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.Display":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.FFormat":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.FileFormat":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.FileSort":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.Format":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.LastFormat":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.LastPageSize":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.LastPresentation":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.LastSort":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.PageSize":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.Presentation":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.SendTo":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.SendToSubmit":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.SetDisplay":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.Sort":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_DisplayBar.sPresentation":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_ResultsController.ResultCount":0, "EntrezSystem2.PEntrez.PubMed.Pubmed_ResultsPanel.Pubmed_ResultsController.RunLastQuery":0};.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }.print-log li { list-style-image: url('/stat?jsevent=print&ncbi_app=entrez&ncbi_db=pubmed&ncbi_pdid=abstract&ncbi_phid=CE8E1AD62612095100000000005E28B9&ncbi_uidlist=19089334'); }.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }

Warning:The NCBI web site requires JavaScript to function. more...

  • NCBI
  • Skip to main content
  • Skip to navigation
  • Resources
    • All Resources
    • Chemicals & Bioassays
    • BioSystems
    • PubChem BioAssay
    • PubChem Compound
    • PubChem Structure Search
    • PubChem Substance
    • All Chemicals & Bioassays Resources...

DNA & RNA

  • BLAST (Basic Local Alignment Search Tool)
  • BLAST (Stand-alone)
  • E-Utilities
  • GenBank
  • GenBank: BankIt
  • GenBank: Sequin
  • GenBank: tbl2asn
  • Genome Workbench
  • Influenza Virus
  • Nucleotide Database
  • PopSet
  • Primer-BLAST
  • ProSplign

Reference Sequence (RefSeq)RefSeqGeneSequence Read Archive (SRA)SplignTrace ArchiveUniGeneUniSTSAll DNA & RNA Resources...

Data & Software
  • BLAST (Basic Local Alignment Search Tool)
  • BLAST (Stand-alone)
  • Cn3D
  • Conserved Domain Search Service (CD Search)
  • E-Utilities
  • GenBank: BankIt
  • GenBank: Sequin
  • GenBank: tbl2asn
  • Genome ProtMap
  • Genome Workbench
  • Primer-BLAST
  • ProSplign
  • PubChem Structure Search
  • SNP Submission Tool
  • Splign
  • Vector Alignment Search Tool (VAST)
  • All Data & Software Resources...

Domains & Structures

  • BioSystems
Cn3DConserved Domain Database (CDD)Conserved Domain Search Service (CD Search)Structure (Molecular Modeling Database)Vector Alignment Search Tool (VAST)All Domains & Structures Resources...

Genes & Expression

  • BioSystems
  • Database of Genotypes and Phenotypes (dbGaP)
  • E-Utilities
  • Gene
  • Gene Expression Omnibus (GEO) Database
  • Gene Expression Omnibus (GEO) Datasets
  • Gene Expression Omnibus (GEO) Profiles
  • Genome Workbench
  • HomoloGene
  • Map Viewer
  • Online Mendelian Inheritance in Man (OMIM)
  • RefSeqGeneUniGene

All Genes & Expression Resources...Genetics & Medicine

  • Bookshelf
  • Database of Genotypes and Phenotypes (dbGaP)
  • Genetic Testing Registry
  • Influenza Virus
  • Map Viewer
  • Online Mendelian Inheritance in Man (OMIM)
  • PubMed
  • PubMed Central (PMC)
  • PubMed Clinical Queries
  • RefSeqGene
  • All Genetics & Medicine Resources...

Genomes & Maps

  • Database of Genomic Structural Variation (dbVar)
  • GenBank: tbl2asn
  • Genome
  • Genome Project
  • Genome ProtMap
  • Genome Workbench
  • Influenza Virus
  • Map Viewer
  • Nucleotide Database
  • PopSet
  • ProSplign
  • Sequence Read Archive (SRA)
  • Splign
  • Trace Archive
  • UniSTS
  • All Genomes & Maps Resources...

HomologyBLAST (Basic Local Alignment Search Tool)BLAST (Stand-alone)BLAST Link (BLink)Conserved Domain Database (CDD)Conserved Domain Search Service (CD Search)Genome ProtMapHomoloGeneProtein ClustersAll Homology Resources...Literature

  • Bookshelf
  • E-Utilities
  • Journals in NCBI Databases
  • MeSH Database
  • NCBI Handbook
  • NCBI Help Manual
  • NCBI News
  • PubMed
  • PubMed Central (PMC)
  • PubMed Clinical Queries
  • PubMed Health
  • All Literature Resources...

Proteins

  • BioSystems
  • BLAST (Basic Local Alignment Search Tool)
  • BLAST (Stand-alone)
  • BLAST Link (BLink)
  • Conserved Domain Database (CDD)
  • Conserved Domain Search Service (CD Search)
  • E-Utilities
  • ProSplign
  • Protein Clusters
  • Protein Database
  • Reference Sequence (RefSeq)
  • All Proteins Resources...

Sequence Analysis

  • BLAST (Basic Local Alignment Search Tool)
  • BLAST (Stand-alone)
  • BLAST Link (BLink)
  • Conserved Domain Search Service (CD Search)
  • Genome ProtMap
  • Genome Workbench
  • Influenza Virus
  • Primer-BLAST
  • ProSplign
  • Splign
  • All Sequence Analysis Resources...

Taxonomy

  • Taxonomy
  • Taxonomy Browser
  • Taxonomy Common Tree
  • All Taxonomy Resources...

Training & Tutorials

  • NCBI Education Page
  • NCBI Handbook
  • NCBI Help Manual
  • NCBI News
  • All Training & Tutorials Resources...

Variation

  • Database of Genomic Structural Variation (dbVar)
  • Database of Genotypes and Phenotypes (dbGaP)
  • Database of Single Nucleotide Polymorphisms (dbSNP)
  • SNP Submission Tool
  • All Variation Resources...

How To

  • All How To
  • Chemicals & Bioassays
  • DNA & RNA
  • Data & Software
  • Domains & Structures
  • Genes & Expression
  • Genetics & Medicine
  • Genomes & Maps
  • Homology
  • Literature
  • Proteins
  • Sequence Analysis
  • Taxonomy
  • Training & Tutorials
  • Variation

About NCBI AccesskeysMy NCBISign in to NCBISign Out PubMed US National Library of Medicine National Institutes of Health

Search databasePubMedAll DatabasesAssemblyBioProjectBioSampleBioSystemsBooksClinVarCloneConserved DomainsdbGaPdbVarEpigenomicsESTGeneGenomeGEO DataSetsGEO ProfilesGSSHomoloGeneMedGenMeSHNCBI Web SiteNLM CatalogNucleotideOMIAOMIMPMCPopSetProbeProteinProtein ClustersPubChem BioAssayPubChem CompoundPubChem SubstancePubMedPubMed HealthSNPSRAStructureTaxonomyToolKitToolKitAllToolKitBookUniGeneUniSTSSearch termSearch

  • Advanced
  • Help

Result Filters

Display Settings:

  • Abstract

Format

  • Summary
  • Summary (text)
  • Abstract
  • Abstract (text)
  • MEDLINE
  • XML
  • PMID List

ApplySend to: jQuery(document).ready( function () { jQuery("#send_to_menu input[type='radio']").click( function () { var selectedValue = jQuery(this).val().toLowerCase(); var selectedDiv = jQuery("#send_to_menu div." + selectedValue); if(selectedDiv.is(":hidden")){ jQuery("#send_to_menu div.submenu:visible").slideUp(); selectedDiv.slideDown(); } }); }); jQuery("#sendto").bind("ncbipopperclose", function(){ jQuery("#send_to_menu div.submenu:visible").css("display","none"); jQuery("#send_to_menu input[type='radio']:checked").attr("checked",false); }); Choose Destination

  • File
  • Clipboard
  • Collections
  • E-mail
  • Order
  • My Bibliography
  • Citation manager
  • FormatSummary (text)Abstract (text)MEDLINEXMLPMID ListCSV

Create File

  • 1 selected item: 19089334
  • FormatSummarySummary (text)AbstractAbstract (text)MEDLINEXMLPMID ListMeSH and Other Data
  • E-mail
  • Subject
  • Additional text

E-mail"SPAM" filtering software noticeAdd to ClipboardAdd to CollectionsOrder articlesAdd to My BibliographyGenerate a file for use with external citation management software.Create File

Handb Exp Pharmacol. 2009;(191):277-308. doi: 10.1007/978-3-540-68964-5_13.NO-independent, haem-dependent soluble guanylate cyclase stimulators.Stasch JP, Hobbs AJ.SourceBayer Schering Pharma AG, Cardiology Research, Pharma Research Center, Wuppertal, 42096, Germany. [email protected] nitric oxide (NO) signalling pathway is altered in cardiovascular diseases, including systemic and pulmonary hypertension, stroke, and atherosclerosis. The vasodilatory properties of NO have been exploited for over a century in cardiovascular disease, but NO donor drugs and inhaled NO are associated with significant shortcomings, including resistance to NO in some disease states, the development of tolerance during long-term treatment, and non-specific effects such as post-translational modification of proteins. The development of pharmacological agents capable of directly stimulating the NO receptor, soluble guanylate cyclase (sGC), is therefore highly desirable. The benzylindazole compound YC-1 was the first sGC stimulator to be identified; this compound formed a lead structure for the development of optimized sGC stimulators with improved potency and specificity for sGC, including CFM-1571, BAY 41-2272, BAY 41-8543, and BAY 63-2521. In contrast to the NO- and haem-independent sGC activators such as BAY 58-2667, these compounds stimulate sGC activity independent of NO and also act in synergy with NO to produce anti-aggregatory, anti-proliferative, and vasodilatory effects. Recently, aryl-acrylamide compounds were identified independent of YC-1 as sGC stimulators; although structurally dissimilar to YC-1, they have a similar mode of action and promote smooth muscle relaxation. Pharmacological stimulators of sGC may be beneficial in the treatment of a range of diseases, including systemic and pulmonary hypertension, heart failure, atherosclerosis, erectile dysfunction, and renal fibrosis. An sGC stimulator, BAY 63-2521, is currently in clinical development as an oral therapy for patients with pulmonary hypertension. It has demonstrated efficacy in a proof-of-concept study, reducing pulmonary vascular resistance and increasing cardiac output from baseline. A full, phase 2 trial of BAY 63-2521 in pulmonary hypertension is underway.PMID: 19089334 [PubMed - indexed for MEDLINE] Publication Types, MeSH Terms, SubstancesPublication Types

  • Review

MeSH Terms

  • Acrylamides/pharmacology
  • Animals
  • Cardiovascular Diseases/drug therapy
  • Cardiovascular Diseases/physiopathology
  • Clinical Trials as Topic
  • Enzyme Activators/pharmacology*
  • Guanylate Cyclase/drug effects*
  • Guanylate Cyclase/metabolism
  • Heme/metabolism*
  • Humans
  • Indazoles/pharmacology
  • Nitric Oxide/metabolism
  • Pyrimidines/pharmacology
  • Receptors, Cytoplasmic and Nuclear/drug effects*
  • Receptors, Cytoplasmic and Nuclear/metabolism
  • Signal Transduction

Substances

  • Acrylamides
  • Enzyme Activators
  • Indazoles
  • Pyrimidines
  • Receptors, Cytoplasmic and Nuclear
  • Nitric Oxide
  • Heme
  • Guanylate Cyclase
  • soluble guanylyl cyclase

LinkOut - more resources

Full Text Sources
  • Springer

Other Literature Sources

  • COS Scholar Universe

Molecular Biology Databases

  • NITRIC OXIDE - HSDB

Supplemental Content

Save itemsAdd to FavoritesView more options

  • Create collection...
  • Manage collections...

loadingRelated citations in PubMed

  • Review NO- and haem-independent soluble guanylate cyclase activators.[Handb Exp Pharmacol. 2009]Review NO- and haem-independent soluble guanylate cyclase activators.
    Schmidt HH, Schmidt PM, Stasch JP. Handb Exp Pharmacol. 2009; (191):309-39.
  • Review Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.[Cardiovasc Drug Rev. 2007]Review Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.Boerrigter G, Burnett JC Jr. Cardiovasc Drug Rev. 2007 Spring; 25(1):30-45.
  • Review Exploring the potential of NO-independent stimulators and activators of soluble guanylate cyclase for the medical treatment of erectile dysfunction.[Curr Pharm Des. 2010]Review Exploring the potential of NO-independent stimulators and activators of soluble guanylate cyclase for the medical treatment of erectile dysfunction.Gur S, Kadowitz PJ, Hellstrom WJ. Curr Pharm Des. 2010 May; 16(14):1619-33.
  • Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension.[ChemMedChem. 2009]Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension.Mittendorf J, Weigand S, Alonso-Alija C, Bischoff E, Feurer A, Gerisch M, Kern A, Knorr A, Lang D, Muenter K, et al. ChemMedChem. 2009 May; 4(5):853-65.
  • Soluble guanylate cyclase stimulators in pulmonary hypertension.[Handb Exp Pharmacol. 2013]Soluble guanylate cyclase stimulators in pulmonary hypertension.Stasch JP, Evgenov OV. Handb Exp Pharmacol. 2013; 218:279-313.

See reviews...See all...Cited by 22 PubMed Central articles

  • The Soluble Guanylate Cyclase Activator BAY 58-2667 Protects against Morbidity and Mortality in Endotoxic Shock by Recoupling Organ Systems.[PLoS One. 2013]The Soluble Guanylate Cyclase Activator BAY 58-2667 Protects against Morbidity and Mortality in Endotoxic Shock by Recoupling Organ Systems.Vandendriessche B, Rogge E, Goossens V, Vandenabeele P, Stasch JP, Brouckaert P, Cauwels A. PLoS One. 2013 Aug 28; 8(8):e72155. Epub 2013 Aug 28.
  • Thrombin has biphasic effects on the nitric oxide-cGMP pathway in endothelial cells and contributes to experimental pulmonary hypertension.[PLoS One. 2013]Thrombin has biphasic effects on the nitric oxide-cGMP pathway in endothelial cells and contributes to experimental pulmonary hypertension.Nickel KF, Laux V, Heumann R, von Degenfeld G. PLoS One. 2013; 8(6):e63504. Epub 2013 Jun 13.
  • Stimulators of soluble guanylyl cyclase: future clinical indications.[Ochsner J. 2013]Stimulators of soluble guanylyl cyclase: future clinical indications.Nossaman BD, Kadowitz PJ. Ochsner J. 2013 Spring; 13(1):147-56.

See all...Related information

  • Related CitationsCalculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the linked from citation displayed first.
  • Compound (MeSH Keyword)PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
  • Substance (MeSH Keyword)PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
  • Cited in PMCFull-text articles in the PubMed Central Database that cite the current articles.
  • Cited in BooksNCBI Bookshelf books that cite the current articles.Recent ActivityClearTurn OffTurn On
    • NO-independent, haem-dependent soluble guanylate cyclase stimulators.NO-independent, haem-dependent soluble guanylate cyclase stimulators.Handb Exp Pharmacol. 2009 ;(191):277-308. doi: 10.1007/978-3-540-68964-5_13.

PubMedEffects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the...Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.Ann Thorac Surg. 2006 Mar ;81(3):935-42.PubMed16488698[uid] (1)PubMed

Related Citations for PubMed (Select 3858885) (140)PubMedPulmonary blood flow and vascular resistance in immature foetal lambsPulmonary blood flow and vascular resistance in immature foetal lambsThe Journal of Physiology. 1964 May; 171(1)80PMCYour browsing activity is empty.Activity recording is turned off.Turn recording back onSee more...

You are here: NCBI > Literature > PubMed Write to the Help Desk

NCBI Education NCBI Help Manual NCBI Handbook Training & Tutorials

  • Resources
  • Chemicals & Bioassays
  • Data & Software
  • DNA & RNA
  • Domains & Structures
  • Genes & Expression
  • Genetics & Medicine
  • Genomes & Maps
  • Homology
  • Literature
  • Proteins
  • Sequence Analysis
  • Taxonomy
  • Training & Tutorials
  • Variation
  • Popular
  • PubMed
  • Bookshelf
  • PubMed Central
  • PubMed Health
  • BLAST
  • Nucleotide
  • Genome
  • SNP
  • Gene
  • Protein
  • PubChem
  • Featured
  • Genetic Testing Registry
  • PubMed Health
  • GenBank
  • Reference Sequences
  • Gene Expression Omnibus
  • Map Viewer
  • Human Genome
  • Mouse Genome
  • Influenza Virus
  • Primer-BLAST
  • Sequence Read Archive
  • NCBI Information
  • About NCBI
  • Research at NCBI
  • NCBI News
  • NCBI FTP Site
  • NCBI on Facebook
  • NCBI on Twitter
  • NCBI on YouTube

External link. Please review our privacy policy. NLM NIH DHHS USA.gov Copyright | Disclaimer | Privacy | Browsers | Accessibility | Contact National Center for Biotechnology Information, U.S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA

PreferencesTurn offExternal link. Please review our privacy policy.

s:Da@ -9Nu]AK9 T81$V6fI$y{2V##']cukN[=so`vEqq,,n pEYF_6G5P|p>\1/6E`r_+y?Ue|{]J'J766m!dgM p$xRi-a0j1Gh%wxgpUJHG#K0@}ww-LM,T[@S ^\S.nFYk76v2Q6vPF w ~KOjx.nHj'! W^{omA7}{cv-akt.c1y| .b1TgUhMk)f+: A20XW&EiE1>TAqEv1gB-PrAH+KDCe7\\B%y3YX#n }V6m$q Mw,m1dIb`3ME_[W}9]zoc =&:=Ti1`6 W2[ErV]{v;YE*zd)\GL[S:|7lYaS0;)uO^w!;Yf-MvH6i@ Z&7l1F'\I O oQsZuGP$2\Ctgb:`K8u9oCFRRaaIB7v3FvH9$F2RH, q'Vq]I#{T?#ov*F M2}('XJ`v>vph%HL 6,1odp 7Q;6o S[/_!CVwKa4Ks3TF Q^,Lj]Eioc_HQI.LO2UYJi;Fk%% MF1i.&-_$[8i$.nRj-qZb{qB ;. 6TcLK5P|'3f'qt%IQRK9?qTy v!Xf;p1DVjR[DIvy)YS8$1E,qqImc9"&`qN_V$XF $or(jRgKxdYYdEg#iRH& ineB_Gm-pApKk'/{8V&1I .5),/